Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free βhCG and PAPP-A

British Journal of Obstetrics and Gynaecology

Volumn 108, Issue 10, 2001, Pages 1043-1046

  Spencer, Kevin ^a  

^a HAROLD WOOD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; AGE; ARTICLE; BAYES THEOREM; BIOCHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; MATHEMATICAL MODEL; PARENT COUNSELING; PRENATAL SCREENING; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL AGE; MIDDLE AGED; NECK; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 0034792982     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-5456(01)00244-3     Document Type: Article

References (10)

1. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy associated plasma protein-A
2. One stop clinic for assessment of risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester
3. Correct estimation of parameters for ultrasound nuchal translucency
4. The mathematical basis of multivariate risk screening; with special reference to screening for Down's syndrome associated pregnancy
5. Maternal age and gestation specific risk for trisomy 21
6. An essay toward solving a problem in the doctrine of chance
7. Age-specific detection and false-positive rates: An aid to counseling in Down's Syndrome risk screening
8. Serum screening for Down's Syndrome: How much do health professionals know?
9. Antenatal screening for Down's Syndrome